Fujifilm gives up developing Avigan drug for COVID-19 treatment
Avigan, initially developed as a drug for influenza, emerged as a potential treatment for the coronavirus during the early stages of the pandemic.
Japan-developed liver cancer screening system to be introduced in Thailand
Fujifilm has been working toward introducing the system with the Thai Association for the Study of the Liver and the country's health ministry.
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
Fujifilm says pivot to health care and chips paid off in pandemic
Over the past decade, Fujifilm parlayed its expertise in film and chemicals to move into medical diagnostics, pharmaceutical manufacturing and supplying materials to chipmakers.
Fujifilm says it can make detection kits for new COVID-19 variants in a month
The Japanese firm has developed a kit that can identify the L452R variant, first identified in India and California and recently found in Tokyo.
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
Fujifilm to restart trial of Avigan to treat COVID-19, report says
Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive.
The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza. Carelink will use Fujifilm's data on Avigan's treatment of novel coronavirus infections and influenza to seek imported drug approval ...
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Japan planning quickest-ever approval for anti-viral drug Avigan
According to sources, the government had already mapped out the drug's approval process by the time a Fujifilm unit disclosed data from clinical studies.
Fujifilm completes delayed Avigan clinical test and looks to government application
Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the antivirus drug. Fujifilm Toyama Chemical Co., a subsidiary of Fujifilm Holdings, is conducting analysis of ...
